HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taco W Kuijpers Selected Research

autosomal recessive Candidiasis familial chronic mucocutaneous

10/2016Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.
7/2014Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects.
8/2013Cutaneous manifestations of primary immunodeficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taco W Kuijpers Research Topics

Disease

29Neoplasms (Cancer)
12/2022 - 03/2009
27Infections
01/2022 - 07/2004
14Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2020 - 04/2003
12Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2002
12Inflammation (Inflammations)
01/2021 - 08/2003
9Chronic Granulomatous Disease
11/2022 - 03/2003
8Virus Diseases (Viral Diseases)
01/2021 - 04/2003
8Neutropenia
01/2021 - 05/2004
7Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2020 - 02/2008
6Aneurysm (Aneurysms)
12/2022 - 02/2011
5Atypical Hemolytic Uremic Syndrome
10/2020 - 01/2018
5Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2020 - 01/2013
4COVID-19
06/2022 - 11/2021
4Breast Neoplasms (Breast Cancer)
01/2022 - 11/2011
4Meningococcal Infections
01/2022 - 09/2005
4Hemorrhage
01/2021 - 05/2009
4Thrombocytopenia (Thrombopenia)
01/2020 - 05/2013
4Fever (Fevers)
11/2016 - 01/2012
4Disease Progression
01/2013 - 01/2002
3Leukemia
01/2022 - 01/2016
3Atherosclerosis
09/2021 - 12/2014
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2021 - 01/2016
3Autosomal Recessive 3 Severe Congenital Neutropenia
01/2021 - 02/2011
3Bacterial Infections (Bacterial Infection)
01/2021 - 07/2008
3Primary Immunodeficiency Diseases
01/2021 - 01/2014
3Arthritis (Polyarthritis)
01/2020 - 01/2008
3Hemolytic Anemia
01/2020 - 01/2014
3Sepsis (Septicemia)
01/2020 - 11/2012
3Disease Susceptibility (Diathesis)
10/2019 - 02/2011
3Tics (Tic)
11/2017 - 07/2014
3autosomal recessive Candidiasis familial chronic mucocutaneous
10/2016 - 08/2013
3Rubella (German Measles)
06/2013 - 04/2003
3Mumps
06/2013 - 04/2003
3Measles
06/2013 - 04/2003
3Shwachman-Diamond Syndrome
01/2013 - 03/2009
2Thrombosis (Thrombus)
12/2022 - 01/2012
2Multiple Sclerosis
01/2022 - 01/2022
2Rheumatoid Arthritis
01/2022 - 01/2016
2Neuroblastoma
08/2021 - 01/2021
2Type III Leukocyte Adhesion Deficiency
01/2021 - 05/2009
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2021 - 01/2014
2Mycoses (Diseases, Fungus)
01/2020 - 07/2014
2Hemolysis
01/2020 - 01/2018
2Communicable Diseases (Infectious Diseases)
01/2020 - 01/2013
2Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
12/2019 - 09/2008
2Mitochondrial Diseases (Mitochondrial Disease)
11/2019 - 11/2016
2Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2018 - 12/2014
2Synovitis
11/2017 - 04/2013
2Cognitive Dysfunction
02/2017 - 03/2016

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2009
17AntibodiesIBA
12/2022 - 08/2006
17Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2013
13Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 02/2011
11Complement System Proteins (Complement)IBA
01/2022 - 01/2010
11Immunoglobulin G (IgG)IBA
11/2021 - 05/2013
7Complement Factor H (Factor H)IBA
01/2022 - 01/2018
7Immunoglobulins (Immunoglobulin)IBA
01/2021 - 06/2009
7AutoantibodiesIBA
10/2020 - 01/2010
6NADPH Oxidases (NAD(P)H oxidase)IBA
01/2018 - 03/2003
5AntigensIBA
06/2022 - 01/2010
5Inosine Triphosphate (ITP)IBA
01/2022 - 02/2008
5Trastuzumab (Herceptin)FDA Link
01/2022 - 11/2011
5IntegrinsIBA
01/2021 - 01/2002
5Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
12/2012 - 04/2003
4Leukocyte Elastase (Neutrophil Elastase)IBA
01/2021 - 09/2005
4CytokinesIBA
01/2021 - 04/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 03/2003
4Monoclonal AntibodiesIBA
01/2020 - 06/2007
3Immunosuppressive Agents (Immunosuppressants)IBA
06/2022 - 01/2014
3Fc Receptors (Fc Receptor)IBA
08/2021 - 01/2018
3C-Reactive ProteinIBA
01/2021 - 01/2020
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 11/2005
3Contrast MediaIBA
01/2020 - 11/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2019 - 07/2004
3thiamine triphosphorate (TTP)IBA
11/2017 - 07/2014
3Chemotactic FactorsIBA
10/2016 - 04/2008
2Pharmaceutical PreparationsIBA
12/2022 - 01/2019
2Messenger RNA (mRNA)IBA
01/2022 - 01/2016
2dinutuximabIBA
08/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 09/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 08/2003
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 01/2020
2Polysaccharides (Glycans)IBA
01/2021 - 01/2017
2Interleukin-6 (Interleukin 6)IBA
12/2020 - 04/2008
2Immunoglobulin A (IgA)IBA
01/2020 - 05/2013
2Pancreatic Elastase (Elastase)IBA
01/2020 - 09/2005
2Antirheumatic Agents (DMARD)IBA
01/2020 - 01/2019
2GadoliniumIBA
06/2019 - 11/2017
2NF-kappa B (NF-kB)IBA
01/2019 - 05/2009
2Ribosomal Proteins (Ribosomal Protein)IBA
03/2017 - 01/2014
2Immunoglobulin E (IgE)IBA
01/2017 - 10/2013
2LigandsIBA
07/2016 - 01/2010

Therapy/Procedure

23Therapeutics
12/2022 - 09/2003
8Drug Therapy (Chemotherapy)
01/2021 - 07/2008
8Highly Active Antiretroviral Therapy (HAART)
02/2017 - 09/2003
6Immunotherapy
01/2021 - 01/2015
3Transplantation
11/2019 - 01/2013
3Hematopoietic Stem Cell Transplantation
01/2017 - 07/2006
2Antibiotic Prophylaxis
01/2021 - 11/2014
2Organ Transplantation
01/2019 - 02/2015